Loading interface...

Evacarb 250 Injection

Manufactured byCelon Labs
ContainsCarboprost
Description

Evacarb 250 Injection is used for the management of excessive bleeding after delivery. It is also used for the termination of pregnancy. It is not recommended for use unless there is a definite need.

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now

Substitutes

List of substitutes for Evacarb 250 Injection

Femiprost 250 mcg Injection
Zydus Cadila

Side effects

Major & minor side effects for Evacarb 250 Injection

  • Headache
  • Irregular heartbeat
  • Skin irritation and rashes
  • Nausea and Vomiting
  • Shortness of breath
  • Stomach cramps and pain
  • Dizziness and lightheadedness
  • Diarrhea

Uses of Evacarb 250 Injection

What is it prescribed for?

  • Termination of pregnancy
  • Postpartum bleeding
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed immediately after the administration of the dose.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    Use of this medicine is not recommended for pregnant women other than for the termination of pregnancy. Otherwise, the risk of birth defects and other abnormalities are very high.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

Allergy

This medicine is not recommended for use if you have a known allergy to carboprost or any other inactive ingredients present in the formulation.

Pelvic Inflammatory Disease

This medicine is not recommended for use in patients with acute pelvic inflammatory disease due to the increased risk of worsening of the patient's condition.

Liver Disease

This medicine is not recommended for use in patients with liver diseases due to the increased risk of worsening of the patient's condition.

Lung diseases

This medicine is not recommended for use in patients with lung diseases due to the increased risk of worsening of the patient's condition.

Kidney Disease

This medicine is not recommended for use in patients with kidney diseases due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

Use of this medicine is not recommended for pregnant women other than for the termination of pregnancy. Otherwise, the risk of birth defects and other abnormalities are very high.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.
General warnings

Cardiovascular diseases

This medicine is not recommended for use in patients with a known history of coronary heart disease, peripheral vascular, or hypertension due to the increased risk of worsening of the patient's condition.

Use in children

This medicine is not recommended for use in children and adolescents since the safety and efficacy of use are not clinically established.

Transient fever

This medicine may cause transient temperature increase upon treatment in some patients. Appropriate corrective measures, dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

For hospital use only

This medicine should be administered only by trained obstetrical personnel in a hospital setting with appropriate obstetrical care facilities.

Missed Dose

Since this medicine is administered by a qualified healthcare professional in the clinical or hospital setting, the likelihood of a missed dose is very low.

Overdose

Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Dinoprostone

Oxytocin

Methylergometrine

Disease interactions

Asthma

This medicine should be used with extreme caution in patients with asthma due to the increased risk of bronchospasm, decreased pulmonary blood flow, and/or increased pulmonary arterial pressure. Report any unusual symptoms to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

Glaucoma

This medicine should be used with caution in patients with glaucoma due to the increased risk of adverse effects. Report any unusual symptoms to the doctor on priority. Close monitoring of the clinical condition, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions
Information not available.
This medicine should be administered only by trained obstetrical personnel in a hospital setting with appropriate obstetrical care facilities. Detect whether the patient is allergic to this medicine before initiating the treatment.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine acts on the smooth muscle of the uterus to induce uterine contractions.
Legal Status

Approved

Approved

Unknown

Approved

Classification

Category

Uterotonic agents, Abortifacient

Schedule

Schedule H

[Internet]. Accessdata.fda.gov. 2018 [cited 31 December 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/017989s019lbl.pdf

[Internet]. Medicines.org.uk. 2018 [cited 31 December 2018]. Available from:

https://www.medicines.org.uk/emc/files/pil.1084.pdf

[Internet]. Drugbank.ca. 2018 [cited 31 December 2018]. Available from:

https://www.drugbank.ca/drugs/DB00429

[Internet]. Dailymed.nlm.nih.gov. 2018 [cited 31 December 2018]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3d282998-ff0c-480a-bd80-155606ef0a65
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 3 Sep 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.